Company intelligence / Profile preview

Toklat

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Toklat is a stealth-mode biotechnology company backed by ARCH Venture Partners. Incorporated in 2023, the company is part of a portfolio of early-stage life science ventures focused on developing transformative therapeutic solutions. While specific details regarding its platform technology and therapeutic focus remain undisclosed, it is led by prominent industry figures and venture capitalists. The company represents ARCH's strategy of incubating high-potential startups in the immunology, oncology, or genetic medicine spaces.

Industry: Biotech

Beyond the preview

Go deeper on Toklat.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toklat.

Explore the full profile